Therefore, both 1) pre-existing hypertension with higher circulating AII levels and activation of renal AT1R, and 2) AII concentration increase by CDDP treatment may contribute to the worsening of CDDP toxic effects in the kidneys. This evidence concerns the gene AGTR1 and hypertensive disorder.